An ABA coverage exclusion and a clinical recommendation are different decisions. The payer or plan applies its benefit, contract, and coverage rules. A qualified clinician evaluates the person's needs, goals, risks, preferences, evidence, and alternatives within scope. Record both decisions and their sources, explain review and funding options accurately, and avoid presenting coverage loss as proof that care is clinically inappropriate or a recommendation as a payment guarantee.

Define Hana's coverage-exclusion and clinical-recommendation separation control

Hana's record contains parallel clinical, payer, client, and operations tracks. The coverage track identifies the product, governing plan source, exclusion, notice, and review rights. The clinical track identifies the qualified author, assessment, recommendation, uncertainty, and review date.

Build the coverage-and-clinical decision record

Record person; decision-maker; client priorities; clinician and credentials; assessment; recommendation; alternatives; payer and product; benefit source; exclusion; medical policy; authorization; notice; appeal right; self-pay or other funding route; capacity; family communication; claim state; owner; and review. Structured fields preserve identity, authority, source, version, level, clock, calculation, action, correction, evidence, hold, retest, and closure. Narrative captures clinical meaning, uncertainty, disagreement, accessibility, family communication, privacy, legal deferral, and each accountable owner's rationale.

Run Hana's workflow

Hana verifies the payer notice and plan source while the qualified clinician decides whether the recommendation remains appropriate. The person or authorized decision-maker receives an accessible explanation of the distinction, available review paths, practical options, and unresolved costs.

Assign decisions to qualified owners

Payer coverage authority does not become treating-clinician authorship. Clinical recommendation does not create a benefit, authorization, network status, provider availability, affordability, claim acceptance, or payment.

Work through Hana's fictional example

Hana reviews 12 fictional cases. Five have a clear exclusion with complete notice, three have a partial limitation, one has an authorization denial rather than an exclusion, one has conflicting plan documents, one lacks an accessible explanation, and one lacks a current clinical review. Nine reach a complete decision record. Three remain open. This synthetic cohort tests control logic and arithmetic only. It creates no coding, coverage, authorization, appeal, payment, client-balance, disclosure, refund, overpayment, recovery, or legal conclusion for a real person, provider, plan, claim, notice, or payment.

Calculate Hana's measures

Record readiness is 9 of 12 cases, or 75.0%. Appeal and continuation outcomes are reported separately once their windows mature. Cases, clinical recommendations, payer determinations, authorizations, claims, and funding paths stay distinct.

Address the main coverage-exclusion and clinical-recommendation separation risk

Telling a family that a service is unnecessary because it is excluded can misrepresent both decisions. Promising that a strong clinical letter will secure coverage can create false expectations and delay alternatives.

Test the coverage-and-clinical decision record against exceptions

Hana tests explicit exclusion, partial benefit, age or setting limit, product conflict, authorization denial, clinical change, self-pay option, other funding, inaccessible notice, and client dissent. Each fixture retains source version, expected state, actual state, affected unit, safeguard, owner, repair, retest, and disposition. Failed, unknown, dismissed, quarantined, and held items remain in the predeclared cohort.

Document the stop condition

Pause coverage claims, financial commitments, and client balances when the governing source or notice is unresolved. Immediate clinical safety and transition needs remain with qualified decision-makers.

Hand off open work with evidence

Hana's handoff includes the payer source and decision, clinical author and recommendation, client priorities, communication access, review rights, deadline, funding options, capacity limits, and owners.

Verify Hana's release evidence

A reviewer checks that each sentence attributes the decision correctly and that estimates carry their assumptions. The record states what remains unknown and the date each source must be rechecked.

Maintain Hana's control over time

To separate an ABA coverage exclusion from a clinical recommendation, Hana keeps decision authors and sources visible. She reviews cases after plan, product, contract, clinical, capacity, or family changes. Updated coverage never silently overwrites the historical determination, and updated clinical judgment retains its qualified author and date. She rechecks every open review right and family estimate after a source changes.

Run Hana's independent review

Hana assigns a reviewer who did not build the coverage-and-clinical decision record. The reviewer reconstructs the coverage-exclusion and clinical-recommendation separation issue, source, state, clock, evidence, calculation, action, and close. Earlier versions, failed tests, unknowns, dismissals, and holds remain available. Hidden exceptions, missing authority, unexplained dates, overwritten history, or unsupported financial action fail review.

Anchor the claim and disputed state

Current 45 CFR 162.1102 identifies the adopted professional-claim standard. Hana preserves the submitted claim, payer response, and exact disputed state before applying the coverage-exclusion and clinical-recommendation separation workflow. A later screen label cannot silently replace the underlying transaction, notice, or adjudication.

Keep Medicare correction and appeal examples in scope

CMS's current redetermination page says a Medicare fee-for-service appellant generally has 120 days from receipt of the initial determination and directs minor errors or omissions to the reopening route. Chapter 34 describes that Medicare reopening process. Hana treats both as Medicare examples rather than universal payer instructions.

Distinguish Medicaid managed-care adverse actions

Current 42 CFR 438.400 defines adverse benefit determinations for MCOs, PIHPs, and PAHPs and separates certain clean-claim payment denials. Section 438.402 assigns enrollee appeal rights, permits provider action only under stated conditions, and uses a 60-calendar-day plan-appeal window. Hana verifies state and plan implementation for coverage-exclusion and clinical-recommendation separation.

Read the source notice

42 CFR 438.404 addresses timely and adequate notice of Medicaid managed-care adverse benefit determinations. Hana stores the complete notice, issuer, action, reason, cited authority, dates, rights, language or accessibility needs, and delivery evidence rather than deriving an appeal from a CARC or portal label alone.

Apply the current Medicare overpayment boundary

Current 42 CFR 401.305 governs specified Medicare overpayments and now includes a timely good-faith related-overpayment investigation provision with an outside limit described in the rule. The CMS Medicare Overpayments guide is program guidance. Hana sends legal interpretation and any report-and-return decision to qualified owners.

Use remittance codes as evidence rather than authority

The X12 external-code-list index defines code-list scopes. The CMS Medicare remittance page explains claim, line, provider-level, and payment information in Medicare context. Hana reads codes with the notice, payer instructions, claim version, and appeal or refund source instead of assigning one universal meaning.

Protect information in payment workflows

HHS payment guidance and minimum-necessary guidance apply when their HIPAA conditions are met. Hana limits appeal and overpayment packets to purpose-needed information, authorized recipients, and approved routes while retaining the evidence required for coverage-exclusion and clinical-recommendation separation.

Keep clinical and compliance authority separate

The CASP public summary and BACB Ethics Code retain their stated scopes. The voluntary OIG GCPG is a compliance framework rather than a payer rule. Hana assigns clinical authorship, coding, payer, accounting, privacy, compliance, and legal decisions to qualified owners.

Related resources

Sources